MAL and cervical cancer: Promoter methylation and transcriptional silencing of MAL protein has been reported for numerous cancers, such as colon cancer [68], cervical cancer [69,70], gastric cancer [71,72], head and neck cancer [73,74], and oral squamous cell carcinoma [75].